Literature DB >> 30288148

Active Surveillance for Prostate Cancer.

Stacy Loeb1.   

Abstract

Entities:  

Year:  2018        PMID： 30288148      PMCID： PMC6168326          DOI： 10.3909/riu0802

Source DB:  PubMed          Journal:  Rev Urol        ISSN： 1523-6161


× No keyword cloud information.
  11 in total

1.  Trends in Management for Patients With Localized Prostate Cancer, 1990-2013.

Authors:  Matthew R Cooperberg; Peter R Carroll
Journal:  JAMA       Date:  2015-07-07       Impact factor: 56.272

2.  A genomic classifier improves prediction of metastatic disease within 5 years after surgery in node-negative high-risk prostate cancer patients managed by radical prostatectomy without adjuvant therapy.

Authors:  Eric A Klein; Kasra Yousefi; Zaid Haddad; Voleak Choeurng; Christine Buerki; Andrew J Stephenson; Jianbo Li; Michael W Kattan; Cristina Magi-Galluzzi; Elai Davicioni
Journal:  Eur Urol       Date:  2014-11-12       Impact factor: 20.096

3.  Cell cycle progression score and treatment decisions in prostate cancer: results from an ongoing registry.

Authors:  E David Crawford; Mark C Scholz; Ashok J Kar; Jeffrey E Fegan; Abebe Haregewoin; Rajesh R Kaldate; Michael K Brawer
Journal:  Curr Med Res Opin       Date:  2014-03-13       Impact factor: 2.580

4.  Decipher Genomic Classifier Measured on Prostate Biopsy Predicts Metastasis Risk.

Authors:  Eric A Klein; Zaid Haddad; Kasra Yousefi; Lucia L C Lam; Qiqi Wang; Voleak Choeurng; Beatrix Palmer-Aronsten; Christine Buerki; Elai Davicioni; Jianbo Li; Michael W Kattan; Andrew J Stephenson; Cristina Magi-Galluzzi
Journal:  Urology       Date:  2016-01-22       Impact factor: 2.649

5.  Active Surveillance for the Management of Localized Prostate Cancer (Cancer Care Ontario Guideline): American Society of Clinical Oncology Clinical Practice Guideline Endorsement.

Authors:  Ronald C Chen; R Bryan Rumble; D Andrew Loblaw; Antonio Finelli; Behfar Ehdaie; Matthew R Cooperberg; Scott C Morgan; Scott Tyldesley; John J Haluschak; Winston Tan; Stewart Justman; Suneil Jain
Journal:  J Clin Oncol       Date:  2016-02-16       Impact factor: 44.544

6.  Complications after prostate biopsies in men on active surveillance and its effects on receiving further biopsies in the Prostate cancer Research International: Active Surveillance (PRIAS) study.

Authors:  Leonard P Bokhorst; Inari Lepistö; Yoshiyuki Kakehi; Chris H Bangma; Tom Pickles; Riccardo Valdagni; Arnout R Alberts; Axel Semjonow; Petra Strölin; Manuel F Montesino; Viktor Berge; Monique J Roobol; Antti Rannikko
Journal:  BJU Int       Date:  2016-02-12       Impact factor: 5.588

7.  Uptake of Active Surveillance for Very-Low-Risk Prostate Cancer in Sweden.

Authors:  Stacy Loeb; Yasin Folkvaljon; Caitlin Curnyn; David Robinson; Ola Bratt; Pär Stattin
Journal:  JAMA Oncol       Date:  2017-10-01       Impact factor: 31.777

8.  Prognostic value of a cell cycle progression signature for prostate cancer death in a conservatively managed needle biopsy cohort.

Authors:  J Cuzick; D M Berney; G Fisher; D Mesher; H Møller; J E Reid; M Perry; J Park; A Younus; A Gutin; C S Foster; P Scardino; J S Lanchbury; S Stone
Journal:  Br J Cancer       Date:  2012-02-23       Impact factor: 7.640

9.  Decipher test impacts decision making among patients considering adjuvant and salvage treatment after radical prostatectomy: Interim results from the Multicenter Prospective PRO-IMPACT study.

Authors:  John L Gore; Marguerite du Plessis; María Santiago-Jiménez; Kasra Yousefi; Darby J S Thompson; Lawrence Karsh; Brian R Lane; Michael Franks; David Y T Chen; Mark Bandyk; Fernando J Bianco; Gordon Brown; William Clark; Adam S Kibel; Hyung L Kim; William Lowrance; Murugesan Manoharan; Paul Maroni; Scott Perrapato; Paul Sieber; Edouard J Trabulsi; Robert Waterhouse; Elai Davicioni; Yair Lotan; Daniel W Lin
Journal:  Cancer       Date:  2017-04-19       Impact factor: 6.860

10.  A 17-gene assay to predict prostate cancer aggressiveness in the context of Gleason grade heterogeneity, tumor multifocality, and biopsy undersampling.

Authors:  Eric A Klein; Matthew R Cooperberg; Cristina Magi-Galluzzi; Jeffry P Simko; Sara M Falzarano; Tara Maddala; June M Chan; Jianbo Li; Janet E Cowan; Athanasios C Tsiatis; Diana B Cherbavaz; Robert J Pelham; Imelda Tenggara-Hunter; Frederick L Baehner; Dejan Knezevic; Phillip G Febbo; Steven Shak; Michael W Kattan; Mark Lee; Peter R Carroll
Journal:  Eur Urol       Date:  2014-05-16       Impact factor: 20.096
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.